Join BJS Academy
BJS Academy>Randomized clinical ...>Long term results of...
Normal View Dyslexic View

Long term results of a randomised trial of stenting of the superficial femoral artery for intermittent claudication

3 July 2023
Randomized clinical trials Vascular
Gunnarson T, Bergman S, Parsson H, Gottsater A, Lindgren H.

Eur J Vasc Endovasc Surg 2023; 65: 513-519.

In this study that included 100 patients, after 30 months, insertion of a stent improved role physical quality of life (QoL) scores, but not overall QoL, compared to best medical therapy. By 60 months QoL was similar in the two groups.

Comment: endovascular intervention for SFA disease is not a good long term solution.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct107
Randomized clinical trials
Randomized clinical trials
Vascular
Long term results of a randomised trial of stenting of the superficial femoral artery for intermittent claudication
Gunnarson T, Bergman S, Parsson H, Gottsater A, Lindgren H.
03072023
Eur J Vasc Endovasc Surg 2023; 65: 513-519.
In this study that included 100 patients, after 30 months, insertion of a stent improved role physical quality of life (QoL) scores, but not overall QoL, compared to best medical therapy. By 60 months QoL was similar in the two groups.
Comment: endovascular intervention for SFA disease is not a good long term solution.
Published on: 3 July 2023
Article ID: rct107

Related articles

Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial.

Terlouw LG, van Dijk LJD, van Noord D, Bakker OJ, Bijdevaate DC, Erler NS et al, on behalf of the Dutch Mesenteric Ischemia Study Group.

16 August 2024

Ten-year outcomes of a randomized clinical trial of endothermal ablation versus conventional surgery for great saphenous varicose veins

Mohamed AH, Howitt A, Rae S, Cai PL, Hitchman L, Wallace T et al.

18 September 2024

Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism. The Kids-DOTT randomized clinical trial.

Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA et al, for the Kids-DOTT Trial investigators and the ATLAS Group.
JAMA 2022; 327: 129-137.

1 February 2022
Home
  • Normal view
  • Dyslexic view
Info
Copied!